CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
Background: Co-expression of CD133, cell surface glycoprotein, and nestin, an intermediate filament protein, was determined to be a marker of neural stem cells and of cancer stem cells in neurogenic tumors. Methods: We examined the expression of CD133 and nestin in ten tumor tissue samples taken fro...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.3233/ACP-2011-0018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850167167800049664 |
|---|---|
| author | Jiri Sana Iva Zambo Jan Skoda Jakub Neradil Petr Chlapek Marketa Hermanova Peter Mudry Alzbeta Vasikova Karel Zitterbart Ales Hampl Jaroslav Sterba Renata Veselska |
| author_facet | Jiri Sana Iva Zambo Jan Skoda Jakub Neradil Petr Chlapek Marketa Hermanova Peter Mudry Alzbeta Vasikova Karel Zitterbart Ales Hampl Jaroslav Sterba Renata Veselska |
| author_sort | Jiri Sana |
| collection | DOAJ |
| description | Background: Co-expression of CD133, cell surface glycoprotein, and nestin, an intermediate filament protein, was determined to be a marker of neural stem cells and of cancer stem cells in neurogenic tumors. Methods: We examined the expression of CD133 and nestin in ten tumor tissue samples taken from patients with rhabdomyosarcomas and in five rhabdomyosarcoma cell lines. Immunohistochemistry and immunofluorescence were used to examine FFPE tumor tissue samples. Cell lines were analyzed by immunofluorescence, immunoblotting, flow cytometry, and RT-PCR. Functional assays (clonogenic in vitro assay and tumorigenic in vivo assay) were also performed using these cell lines. Results: CD133 and nestin were detected in all 10 tumor tissue samples and in all 5 cell lines; however, the frequency of CD133+, Nes+, and CD133+/Nes+ cells, as well as the intensity of fluorescence varied in individual samples or cell lines. The expression of CD133 and nestin was subsequently confirmed in all cell lines by immunoblotting. Furthermore, we observed an increasing expression of CD133 in relation to the cultivation. All cell lines were positive for Oct3/4 and nucleostemin; NSTS-11 cells were also able to form xenograft tumors in mice. Conclusion: Our results represent the first evidence of CD133 expression in rhabdomyosarcoma tissue and in rhabdomyosarcoma cell lines. In addition, the co-expression of CD133 and nestin as well as results of the functional assays suggest a possible presence of cancer cells with a stem-like phenotype in these tumors. |
| format | Article |
| id | doaj-art-e23d8c57771746ad824c0d263d71901a |
| institution | OA Journals |
| issn | 2210-7177 2210-7185 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Analytical Cellular Pathology |
| spelling | doaj-art-e23d8c57771746ad824c0d263d71901a2025-08-20T02:21:16ZengWileyAnalytical Cellular Pathology2210-71772210-71852011-01-0134630331810.3233/ACP-2011-0018CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell LinesJiri Sana0Iva Zambo1Jan Skoda2Jakub Neradil3Petr Chlapek4Marketa Hermanova5Peter Mudry6Alzbeta Vasikova7Karel Zitterbart8Ales Hampl9Jaroslav Sterba10Renata Veselska11Laboratory of Tumor Biology and Genetics, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic1st Institute of Pathologic Anatomy, St. Anne's University Hospital and School of Medicine, Masaryk University, Brno, Czech RepublicLaboratory of Tumor Biology and Genetics, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech RepublicLaboratory of Tumor Biology and Genetics, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech RepublicLaboratory of Tumor Biology and Genetics, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech Republic1st Institute of Pathologic Anatomy, St. Anne's University Hospital and School of Medicine, Masaryk University, Brno, Czech RepublicDepartment of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech RepublicCenter of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematooncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech RepublicDepartment of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech RepublicDepartment of Histology and Embryology, School of Medicine, Masaryk University, Brno, Czech RepublicDepartment of Pediatric Oncology, University Hospital Brno and School of Medicine, Masaryk University, Brno, Czech RepublicLaboratory of Tumor Biology and Genetics, Department of Experimental Biology, School of Science, Masaryk University, Brno, Czech RepublicBackground: Co-expression of CD133, cell surface glycoprotein, and nestin, an intermediate filament protein, was determined to be a marker of neural stem cells and of cancer stem cells in neurogenic tumors. Methods: We examined the expression of CD133 and nestin in ten tumor tissue samples taken from patients with rhabdomyosarcomas and in five rhabdomyosarcoma cell lines. Immunohistochemistry and immunofluorescence were used to examine FFPE tumor tissue samples. Cell lines were analyzed by immunofluorescence, immunoblotting, flow cytometry, and RT-PCR. Functional assays (clonogenic in vitro assay and tumorigenic in vivo assay) were also performed using these cell lines. Results: CD133 and nestin were detected in all 10 tumor tissue samples and in all 5 cell lines; however, the frequency of CD133+, Nes+, and CD133+/Nes+ cells, as well as the intensity of fluorescence varied in individual samples or cell lines. The expression of CD133 and nestin was subsequently confirmed in all cell lines by immunoblotting. Furthermore, we observed an increasing expression of CD133 in relation to the cultivation. All cell lines were positive for Oct3/4 and nucleostemin; NSTS-11 cells were also able to form xenograft tumors in mice. Conclusion: Our results represent the first evidence of CD133 expression in rhabdomyosarcoma tissue and in rhabdomyosarcoma cell lines. In addition, the co-expression of CD133 and nestin as well as results of the functional assays suggest a possible presence of cancer cells with a stem-like phenotype in these tumors.http://dx.doi.org/10.3233/ACP-2011-0018 |
| spellingShingle | Jiri Sana Iva Zambo Jan Skoda Jakub Neradil Petr Chlapek Marketa Hermanova Peter Mudry Alzbeta Vasikova Karel Zitterbart Ales Hampl Jaroslav Sterba Renata Veselska CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines Analytical Cellular Pathology |
| title | CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines |
| title_full | CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines |
| title_fullStr | CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines |
| title_full_unstemmed | CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines |
| title_short | CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines |
| title_sort | cd133 expression and identification of cd133 nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines |
| url | http://dx.doi.org/10.3233/ACP-2011-0018 |
| work_keys_str_mv | AT jirisana cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT ivazambo cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT janskoda cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT jakubneradil cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT petrchlapek cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT marketahermanova cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT petermudry cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT alzbetavasikova cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT karelzitterbart cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT aleshampl cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT jaroslavsterba cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines AT renataveselska cd133expressionandidentificationofcd133nestinpositivecellsinrhabdomyosarcomasandrhabdomyosarcomacelllines |